Gene · 3068
Papers1,340
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,340
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetically supported targets and drug repurposing for sleep disorders: a Mendelian randomization systematic study. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42760376 | PubTator, text mining | PubMed |
| Malic enzyme 1 senses L-lactate to determine tumor heterogeneity. | Signal Transduct Target Ther | 2026 | 42728262 | PubTator, text mining | PubMed |
| HDGF induces inflammatory cancer-associated fibroblast formation through ENO1-mediated glycolytic reprogramming in esophageal squamous-cell carcinoma. | Cancer Lett | 2026 | 42595076 | PubTator, text mining | PubMed |
| Lactylation-driven metabolic reprogramming promotes osteosarcoma malignancy via HDGF-mediated proliferation and immune modulation. | Front Immunol | 2026 | 42245633 | PubTator, text mining | PubMed |
| HDGF as a Novel Serological Marker for Proliferative Diabetic Retinopathy: A Mendelian Randomization and Cross-Sectional Study. | Transl Vis Sci Technol | 2026 | 42171425 | PubTator, text mining | PubMed |
| Multiscale Embedded Gene Co-Expression Network Combined with Mendelian Randomisation Analysis for the Molecular Pathogenesis of Breast Cancer. | J Coll Physicians Surg Pak | 2026 | 42015432 | PubTator, text mining | PubMed |
| Inhibition of circZFX suppresses malignant phenotypes in cholangiocarcinoma via the miR-654-3p/HDGF and YAP1 signaling activation. | Biol Direct | 2026 | 42010436 | PubTator, text mining | PubMed |
| Integrated spatial transcriptomics and pan-cancer XGBoost modeling uncover spatial drivers of immune exclusion and predict immunotherapy response. | Cancer Immunol Immunother | 2026 | 41925746 | PubTator, text mining | PubMed |
| Noninvasive, Rapid, and Precise Identification of Esophageal Cancer via Salivary Extracellular Vesicle-Based Diagnosis. | ACS Nano | 2026 | 41910207 | PubTator, text mining | PubMed |
| The role of miRNAs in the development of brain metastases originating from lung adenocarcinoma. | Front Genet | 2026 | 41799343 | PubTator, text mining | PubMed |
| Genetic Evidence Reveals Causal Effect of Circulating Proteome on Random Glucose: A Mendelian Randomization Study. | J Diabetes Res | 2026 | 41789253 | PubTator, text mining | PubMed |
| Research Progress on the Biological Function, Disease-Driving Mechanism and Clinical Targeting Strategies of G3BP2. | Molecules | 2026 | 41752399 | PubTator, text mining | PubMed |
| Lactylation-based machine algorithm combined with multi-omics analysis to predict prognosis in cervical cancer. | Oncol Lett | 2026 | 41743011 | PubTator, text mining | PubMed |
| Histone methyltransferase SMYD1: playing a crucial role in disease progression. | Front Mol Biosci | 2026 | 41737831 | PubTator, text mining | PubMed |
| Cross-ancestry comparison of aptamer and antibody protein measures. | Nat Commun | 2026 | 41571639 | PubTator, text mining | PubMed |
| Multi-Omics Analysis Reveals That the MAZ/HDGF Regulatory Axis Drives High-Grade Serous Ovarian Cancer Progression by Modulating Glycolysis and M2 Macrophage Polarization. | IUBMB Life | 2026 | 41467359 | PubTator, text mining | PubMed |
| Proteome-wide association study identifies novel Alzheimer's disease-associated proteins. | J Alzheimers Dis | 2026 | 41460672 | PubTator, text mining | PubMed |
| A KAT7-lncPVT1 positive feedback loop promotes lung cancer carcinogenesis and therapy resistance via H3K14ac/HDGF/PI3K/AKT Axis. | Int J Biol Macromol | 2026 | 41418975 | PubTator, text mining | PubMed |
| MiR-769-5p, Which Targets HDGF, Inhibits Cell Proliferation and Invasion in Nonsmall Cell Lung Cancer. | Cancer Biother Radiopharm | 2026 | 34978893 | PubTator, text mining | PubMed |
| Gastric cancer organoids: a promising model for personalized treatment of gastric cancer. | Front Cell Dev Biol | 2025 | 41725823 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3068/papers